Geode Capital Management LLC Raises Position in Jaguar Health, Inc. (NASDAQ:JAGX)

Geode Capital Management LLC grew its position in shares of Jaguar Health, Inc. (NASDAQ:JAGX) by 18.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 96,716 shares of the biotechnology company’s stock after buying an additional 14,895 shares during the quarter. Geode Capital Management LLC’s holdings in Jaguar Health were worth $98,000 as of its most recent filing with the Securities & Exchange Commission.

Separately, Virtu Financial LLC bought a new stake in shares of Jaguar Health during the 3rd quarter valued at about $35,000. 12.04% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Separately, StockNews.com began coverage on Jaguar Health in a research note on Friday, March 28th. They issued a “sell” rating for the company.

Jaguar Health Price Performance

Shares of JAGX opened at $12.98 on Monday. Jaguar Health, Inc. has a 52-week low of $4.02 and a 52-week high of $532.50. The company has a debt-to-equity ratio of 1.65, a quick ratio of 1.36 and a current ratio of 1.84. The business has a fifty day moving average of $8.49 and a 200 day moving average of $18.85.

About Jaguar Health

Jaguar Health, Inc, a commercial stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress, specifically chronic and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products.